Design and Synthesis of NTQ1062, a new Akt Inhibitor Clinical Candidate (Synfacts, 2022)
Keywords: structure–activity relationship; ATP competitive Akt inhibitors; cancer therapy; antitumor drugs; enzyme inhibitors